0000000000651569

AUTHOR

Vania Lombardo

showing 3 related works from this author

Case report: acute portal vein thrombosis associated with acute cytomegalovirus infection in an immunocompetent adult

2017

Cytomegalovirus (CMV) infection is usually asymptomatic and self-limiting in healthy individuals, but significant complications can develop in immunosuppressed patients. Venous or arterial thromboembolic phenomena are uncommon yet very serious complications of CMV infection. Most published reports describe immunosuppressed patients, but thrombotic events in CMV-infected immunocompetent individuals may also occur. We describe the case of an immunocompetent young man with acute CMV hepatitis that was complicated with portal vein thrombosis (PVT). We also review the literature regarding the association between PVT and CMV in immunocompetent patients. Thromboembolism is an underestimated but si…

AdultMalemedicine.medical_specialtyPediatricsRadiology Nuclear Medicine and ImagingSettore MED/09 - Medicina InternaCmv hepatitisUsually asymptomaticCongenital cytomegalovirus infectionCase Report030204 cardiovascular system & hematologyHepatic veinPathogenesisDiagnosis Differential03 medical and health sciences0302 clinical medicineUltrasoundmedicineInternal MedicineHumansUltrasonography Doppler ColorPortal vein thrombosiVenous Thrombosisbusiness.industryPortal VeinDopplervirus diseasesCytomegaloviruGeneral Medicinemedicine.diseaseSurgeryPortal vein thrombosisCytomegalovirus infectionHealthy individualsCytomegalovirus Infections030211 gastroenterology & hepatologyImmunocompetentComplicationbusinessImmunocompetence
researchProduct

Hemophagocytic syndrome in a patient with disseminated tuberculosis: a case report

2018

Hemophagocytic syndrome (HS) is a rare disorder of the immune system. It is characterized by fever, lymphadenopathy, hepatosplenomegaly, cytopenia and hyperferritinemia. The cause differs in each country suggesting a specific genetic background and epidemiology of infections, and it can be associated with malignant diseases. A rare cause of HS is tuberculosis (TB), we describe a case of HS associated with disseminated Mycobacterium tuberculosis (MT) infection in a patient from Sudan. He presented diarrhea, fever, pancytopenia, thickened and dilated bowel loops and lymph nodes enlargement at ultrasound and computed tomography scan. A bone marrow biopsy performed to rule out a lymphoma reveal…

Pathologymedicine.medical_specialtySettore MED/09 - Medicina InternaTuberculosisHepatosplenomegalyMycobacterium tuberculosis.lcsh:MedicineMycobacterium tuberculosiMycobacterium tuberculosisBiopsymedicineHemophagocytic lymphohistiocytosis disseminated tuberculosis; Hemophagocytic syndrome; Mycobacterium tuberculosis; Medicine (all)hemophagocytic lymphohistiocytosis disseminated tuberculosisCytopeniabiologymedicine.diagnostic_testbusiness.industryMedicine (all)lcsh:RGeneral Medicinebiology.organism_classificationmedicine.diseasePancytopeniaLymphomaBronchoalveolar lavageHemophagocytic lymphohistiocytosis disseminated tuberculosimedicine.symptombusinessHemophagocytic syndromeItalian Journal of Medicine
researchProduct

Rivaroxaban-induced hepatotoxicity

2017

Aim/Objective/Background Direct-acting oral anticoagulant drugs are marketed worldwide for the primary and secondary prevention and treatment of thromboembolic disorders. Rivaroxaban, an oral, direct factor Xa inhibitor, is one of the most used. Rivaroxaban-induced hepatotoxicity is unusual, although a number of adverse reports have recently been reported. Here, we report two new cases of rivaroxaban-induced hepatitis. Methods A systematic search of case reports on the MEDLINE database encompassing the years 2008–2016 was carried out.Additional references were obtained following a manual search of the retrieved papers. We report two new cases of adverse events occurred in patients treated w…

Malemedicine.medical_specialtySettore MED/09 - Medicina Internamedicine.drug_mechanism_of_actionFactor Xa InhibitorMEDLINE030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRivaroxabanInternal medicinemedicineHumansAgedAged 80 and overSecondary preventionRivaroxabanHepatologybusiness.industryGastroenterologydrug-induced liver injury hepatotoxicity pharmacovigilancerivaroxabanOral anticoagulantFemale030211 gastroenterology & hepatologyChemical and Drug Induced Liver InjurybusinessFactor Xa Inhibitorsmedicine.drugEuropean Journal of Gastroenterology & Hepatology
researchProduct